Draft:SiPhox Health
From Wikipedia, the free encyclopedia
SiPhox Health is an American health technology company that develops at-home blood testing products using silicon photonics. Founded in 2020 and headquartered in Burlington, Massachusetts, the company offers mail-in blood testing kits and is developing a consumer diagnostic device.
Submission declined on 7 February 2026 by TheObsidianGriffon (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 4 February 2026 by Pythoncoder (talk). This draft reads like an advertisement. Wikipedia is an encyclopedia, not a platform for promotion or marketing. Drafts that are exclusively promotional may be deleted without notice.
Declined by Pythoncoder 50 days ago.Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page. Rewrite the draft to remove:
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject. If you have a conflict of interest (e.g. you are the subject, an employee, or a relative) or are being paid to edit, you must disclose this to comply with Wikipedia's Terms of Use. | |
| Company type | Private |
|---|---|
| Industry | Health technology |
| Founded | 2020 |
| Founders | Michael Dubrovsky, Diedrik Vermeulen |
| Headquarters | Burlington, Massachusetts, U.S. |
| Website | www.siphoxhealth.com |
History
SiPhox Health was founded in 2020 by Michael Dubrovsky and Diedrik Vermeulen, who met at the Massachusetts Institute of Technology.[1] The company's technology is based on silicon photonics, which was originally developed for data communications applications.[2]
The company participated in Y Combinator's Summer 2020 accelerator program.[3]
In 2023, SiPhox Health launched a mail-in blood testing service and raised $27 million in funding from Intel Capital and Khosla Ventures.[3][4]
In 2025, The Boston Globe reported that the company planned to release its home testing device within the following year.[5]
Products and technology
Mail-in testing service
SiPhox Health operates a mail-in blood testing service in which users collect samples at home and send them to CLIA/CAP-certified laboratories for analysis.[2] The tests measure biomarkers related to cardiovascular, metabolic, hormonal, and inflammatory health.[2]
SiPhox Home device
The company is developing a countertop diagnostic device called SiPhox Home, which uses silicon photonics and microfluidics to analyze blood samples collected via finger prick.[5] The device was demonstrated at CES 2023.[6]
Technical details of the silicon photonics system were presented at the 2023 IEEE Silicon Photonics Conference.[7]
- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.